Areas of Specialty
Medical Affairs and Commercialisation
At Pharmedsciences, we leverage our extensive network and experience in bench to bedside modern medical affairs and commercialisation.
We offer bespoke consulting and solutions which will drive medical affairs capabilities improving both patient and business outcomes.
- Launch strategy (including Go To Market) and execution including novel measures of success
- Medical affairs talent and capability building
- Social listening on brands/competitors both local and global
- Innovative and tailored medical education
- TA training (haematology/oncology/diagnostics/drug development)
- Inter-hospital preceptorships/masterclasses for your cross functional team, or we bring the preceptorship to you
- Advisory board/round tables live/digital or hybrid including onsite realtime KOL (Key Opinion Leaders) panels at major conferences - as soon as the data are released, you get deep insights from tier 1 KOLS/Minutes and Executive Summary - we can setup these critical meetings in less than 6 weeks
Patient Engagement
Focussing on early access programmes and peri-product launch - we will talk to your patients (with consent from the patient and treating HCP) and bring back regular, deep insights to help build your patient-informed strategy. The utmost respect for patient details and compliance will be at the centre of this but you will get rich patient experiences, stories, data and all at a crucial time for launch strategies. Patient Medical Education will also be a focus of PharmedSciences
Industry Engagement
Getting an idea, concept or true collaboration (or even a role in industry) to fruition with pharmaceutical companies can be haphazard, protracted and subject to difficult processes with often no outcome. Pharmedsciences will bridge this gap for external stakeholders who want to engage companies at both a local and global level to achieve investment, partnerships and collaborations. Pharmedsciences have reach into every Australian pharmaceutical company and the inside knowledge needed to engage effectively.
Matt Britland BSc (onc), MMedSc (Drug Dev) DrPH (Cand)
Matt is an experienced medical affairs leader and Medical Director with a demonstrated history of working in the pharmaceuticals industry in local and global positions and clinical roles for over 20 years. Skilled in Pharmaceutical Medicine, Oncology and Haematology.
Matt's network within the pharmaceutical industry is deep and wide. Pha
Matt is an experienced medical affairs leader and Medical Director with a demonstrated history of working in the pharmaceuticals industry in local and global positions and clinical roles for over 20 years. Skilled in Pharmaceutical Medicine, Oncology and Haematology.
Matt's network within the pharmaceutical industry is deep and wide. Pharmedsciences will leverage this network to build long lasting collaborations.
Matt is a strong professional with a MMedSc focused in Pharmaceutical Medicine and Drug Development from UNSW Australia. Currently working towards DrPH which focuses on the role of Medical Affairs in the Quality use of Medicine (QUM) and its impact on patient outcomes.
Matt is also the President of the Medical Affairs Professionals of Australasia (MAPA) which is the representative association for Medical Affairs in Australia and is dedicated to promoting excellence in pharmaceutical medicine through professional development, networking and advocacy. MAPA is an association of medical directors, medical advisors and medical scientific liaisons working within medical affairs departments of Australian pharmaceutical companies. MAPA has over 700 members. Matt also is on the Executive Committee of MAPS JPAC.